Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPTE pseudogene 2 (TPTEP2), located on chromosome 22, is a non-functional genetic element classified as a pseudogene, most likely originating through genomic duplication events from the TPTE gene family[1][3][5]. Pseudogenes do not code for functional proteins but may impact gene regulation at the RNA level through mechanisms such as miRNA sponging, antisense pairing, and influencing epigenetic patterns[7]. While pseudogene expression (including TPTEP2) has shown relevance in cancer subtype classification and survival prediction, TPTEP2 itself is not a receptor, enzyme, transporter, or transcription factor, and thus not a druggable or therapeutic target in classical pharmacology[2][4][7][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPTE pseudogene 2 (TPTEP2).